In January 2026, Vir Biotechnology reported new positive data from its ongoing SOLSTICE Phase 2 trial in chronic hepatitis delta, where combination therapy with investigational agents tobevibart and ...

Dividend ETFs with unusually high yields have become a core tool for investors who want their portfolios to spin off serious ...

The Lakers have found their standard. The execution is the ultimate test. "Hopefully we can find that consistency," JJ Redick ...

First, the market momentum for Mirum's rare liver disease drug Livmarli should continue. Sales increased 56% year-over-year ...

Vir Biotechnology, Inc. today provided key program updates, including new positive data from the ongoing SOLSTICE Phase 2 trial in chronic hepatitis delta (CHD). Participants receiving the combination ...

BBC Sport's Ask Me Anything team explain if Antoine Semenyo can feature for Manchester City against Newcastle in the Carabao Cup semi-finals.

Explore how VIG and HDV differ in yield, sector focus, and risk—key factors for investors weighing income versus growth ...

On the newly-renovated streets of Ouidah, thousands of Beninese and foreign tourists gathered this week to discover the ...

Chevron shares are up on Thursday as the company navigates complex geopolitical landscapes, particularly regarding potential investments in Venezuela.

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Beta measures price volatility relative to the S&P 500; beta is calculated from five-year weekly returns. The 1-yr return represents total return over the trailing 12 months. SCHD is marginally more ...

SCHD is slightly cheaper to own and currently offers a higher dividend yield than HDV. HDV, however, has delivered bigger returns and a shallower five-year drawdown. Both funds have large exposure to ...